On the other hand, with no claim terms in dispute, San Diego could be correct that time to trial may have been advanced considerably with discovery now limited to other matters. The discovery questions relating to the Hikma and DRL fraud on the Nevada District Court remain, particularly with FTC and DOJ continuing to investigate higher drug prices.
We Amarin shareholders need DOJ and/or FTC to initiate an enforcement action against those entities, Express Scripts, CVS/Caremark predicated on the facts and law set forth in our shareholder Petition for Writ of Certiorari filed a few years back, on which no Court or Federal Cabinet or independent agency has expressed an opinion. More is embedded in my previous posts on the topic.